Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizPatent fight looming over dog cloning; irony as to Hwang's Snuppy patents
By Lawrence B. Ebert, Esq.
Hwang, fired from SNU and now having his own lab in Gyeonggi Province, works for California-based BioArts International, which made headlines for its planned July 5-9 auction rewarding five winners a chance to clone their favorite pets.
BioArts claims RNL Bio has no legal rights to clone dogs as it has an exclusive license for the cloning of animals using somatic cell nuclear transfer (SCNT) technology. The license was granted to Start Licensing and applies to cloning patents developed at the Roslin Institute for the cloning of ``Dolly'' the sheep.
RNL Bio responds that it owns the worldwide license for dog cloning, granted to SNU which held the patents for the cloning of ``Snuppy'' the dog ? a verified Hwang achievement. The Korean company stresses that the technology associated with sheep cloning has never been successful in producing a genetic copy of a dog.
There is the possibility of a legal battle brewing between the world's only two companies involved in commercial dog cloning, which may eventually come down to an ultimate showdown between SNU and Start Licensing.
The situation is ironic. BioArts/Hwang is invoking patent rights from Roslin, while RNL Bio is invoking patent rights obtained from Hwang. The post notes:
Kim Sun-woong, a patent lawyer representing Sooam Biotech Research Center, Hwang's current lab, has a different take. He claims that BioArts' exclusive rights covers all cloning of animals using somatic-cell derived methods, which he calls ``core technology,'' and the SNU patents are just about ``methodology.''
Yes, Hwang's entity is "putting down" the scope and significance of the Hwang patents.
See also -->
http://ipbiz.blogspot.com/2006/05/hwang-saga-patents-still-sore-point.html
http://ipbiz.blogspot.com/2006/07/review-of-book-by-ian-wilmut.html
Full post as published by IPBiz on July 15, 2008 (boomark / email).
Hurricane Ike
Gulf Coast Residents Fight for Compensation
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment










